USD 0.0
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | 4769.00 | 4351.00 | 22.87 Thousand | 14.8 Thousand | - | - |
Gross Profit | -4769.00 | -4351.00 | -22.87 Thousand | -14.8 Thousand | - | - |
Operating Expenses | 494.44 Thousand | 212.31 Thousand | 265.3 Thousand | 1.7 Million | 972.65 Thousand | 267.64 Thousand |
Selling, General and Administrative Expenses | 473.96 Thousand | 608.62 Thousand | 228.69 Thousand | 250.04 Thousand | 511.21 Thousand | 267.64 Thousand |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | 141.51 Thousand | - |
Cost and Expenses | 499.21 Thousand | 216.66 Thousand | 288.17 Thousand | 1.71 Million | 972.65 Thousand | 267.64 Thousand |
Operating Income | -478.73 Thousand | -57.79 Thousand | -251.84 Thousand | -1.71 Million | -972.58 Thousand | -599.27 Thousand |
Interest Expense | - | - | - | - | 2477.00 | 6411.00 |
Income Tax Expense | - | 158.86 Thousand | 18.71 Thousand | -1968.00 | -3366.20 | -584.98 Thousand |
Earnings before Tax | -533.1 Thousand | -375.52 Thousand | -306.89 Thousand | -1.71 Million | -828.72 Thousand | 70.4 Thousand |
Net Income | -533.1 Thousand | -375.52 Thousand | -306.89 Thousand | -1.71 Million | -828.72 Thousand | 70.4 Thousand |
Earnings Per Share Basic | -0.01 | -0.01 | -0.01 | -0.04 | -0.03 | 0.00 |
Earnings Per Share Diluted | -0.01 | -0.01 | -0.01 | -0.04 | -0.03 | 0.00 |
Weighted Average Shares Outstanding | 51.6 Million | 50.52 Million | 50.52 Million | 44.4 Million | 30.33 Million | 33.84 Million |
Weighted Average Shares Outstanding (Diluted) | 51.59 Million | 51.59 Million | 50.52 Million | 44.4 Million | 30.33 Million | 33.84 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -460.54 Thousand | -53.44 Thousand | -228.96 Thousand | -1.69 Million | -972.58 Thousand | -599.27 Thousand |
Earnings Before Tax Margin | - | - | - | - | - | - |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | 1508.00 | 1149.00 | 1084.00 | 4769.00 | 1187.00 | 1444.00 |
Gross Profit | -1508.00 | -1149.00 | -1084.00 | -4769.00 | -1187.00 | -1444.00 |
Operating Expenses | 73.67 Thousand | 76.61 Thousand | 61.84 Thousand | 494.44 Thousand | 191.72 Thousand | 68.88 Thousand |
Selling, General and Administrative Expenses | 73.67 Thousand | 76.61 Thousand | 54.4 Thousand | - | 56.77 Thousand | 61.26 Thousand |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 7837.00 | - | - | - | - | - |
Cost and Expenses | 75.18 Thousand | 77.76 Thousand | 62.92 Thousand | 499.21 Thousand | 192.91 Thousand | 70.33 Thousand |
Operating Income | -75.18 Thousand | -77.76 Thousand | -52.49 Thousand | -465.31 Thousand | -281.32 Thousand | 30.8 Thousand |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | 2.00 | 1.00 | 10.42 Thousand | 33.89 Thousand | -88.41 Thousand | 101.13 Thousand |
Earnings before Tax | -68.67 Thousand | -85.51 Thousand | -73.35 Thousand | -533.1 Thousand | -104.49 Thousand | -171.46 Thousand |
Net Income | -68.67 Thousand | -85.51 Thousand | -73.35 Thousand | -533.1 Thousand | -104.49 Thousand | -171.46 Thousand |
Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | - | -0.00 | -0.00 |
Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | - | -0.00 | -0.00 |
Weighted Average Shares Outstanding | 51.59 Million | 51.59 Million | 51.59 Million | 51.59 Million | 51.59 Million | 51.59 Million |
Weighted Average Shares Outstanding (Diluted) | 51.59 Million | 51.59 Million | 51.59 Million | 51.59 Million | 51.59 Million | 51.59 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -73.67 Thousand | -76.61 Thousand | -51.41 Thousand | - | -280.13 Thousand | 32.25 Thousand |
Earnings Before Tax Margin | - | - | - | - | - | - |
6643
SCTBF
GCSL
033270
GFAIW
BRE2